American Diabetes Association
SupplementaryMaterial.pdf (2.16 MB)

Novel Linkage Peaks Discovered for Diabetic Nephropathy in Individuals With Type 1 Diabetes

Download (2.16 MB)
posted on 2021-01-07, 23:32 authored by Jani Haukka, Niina Sandholm, Erkka Valo, Carol Forsblom, Valma Harjutsalo, Joanne B. Cole, Stuart J. McGurnaghan, Helen M. Colhoun, Per-Henrik Groop
Genome-wide association studies (GWAS) and linkage studies have had only limited success in discovering genome-wide significantly linked regions or risk loci for diabetic nephropathy in individuals with type 1 diabetes (T1D). As GWAS cohorts have grown, they have also included more documented and undocumented familial relationships. Here, we computationally inferred and manually curated pedigrees in a study cohort of more than 6,000 individuals with T1D and their non-diabetic relatives. We performed linkage study for 177 pedigrees consisting of 452 individuals with T1D and their relatives using a genome- wide genotyping array with more than 300,000 SNPs and the PSEUDOMARKER software. The analysis resulted in genome-wide significant linkage peaks on eight chromosomal regions from five chromosomes (logarithm of odds [LOD]>3.3). The highest peak was localized at the HLA region on chromosome 6p, but whether the peak originates from T1D or diabetic nephropathy, remains ambiguous. Of the other significant peaks, the chromosome 4p22 region is localized on top of a gene associated with focal segmental glomerulosclerosis, ARHGAP24, suggesting that the gene may play a role in diabetic nephropathy as well. Furthermore, rare variants have been associated with diabetic nephropathy and chronic kidney disease near the 4q25 peak, localized on top of CCSER1.


This study was supported by funding from the JDRF (Ref. 1SRA-2016-333-M-R), Folkhälsan Research Foundation, Wilhelm and Else Stockmann Foundation, Liv och Hälsa Society, Helsinki University Hospital Research Funds (EVO TYH2018207), Academy of Finland (275614, 299200, and 316664), Novo Nordisk Foundation (NNF OC0013659), and European Foundation for the Study of Diabetes (EFSD) Young Investigator Research Award funds.


Usage metrics



    Ref. manager